TCTR20161103003已完成4 期
Correction of vitamin D deficiency in chronic hepatitis C patients and effect on cytokines responses related to liver fibrotic pathway: A Randomized Double-Blind Placebo Control Study
The Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 58 人开始时间: 2016年11月3日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1.Chronic hepatitis c or CHC cirrhosis child A
- •2. 25-OH vitamin D < 30 ng/ml
排除标准
- •1. HIV, DM, chronic lung disease
- •2. other cause of chronic hepatitis
- •3. preganancy
- •4. active bacterial infection
- •5. immunosuppresive drug
- •6. GFR < 60
研究者
相似试验
已完成
不适用
Correction of Vitamin D Deficiency in Chronic Hepatitis C Patients who Had Sustained Virologic Response After Direct-acting Agent Therapy : Effect on Serum Hepatic Fibrogenesis MarkersChronic hepatitis CLiver fibrosisVitamin DLiver fibrosisChronic hepatitis CTGF-β1TCTR20171206003The Gastroenterological Association of Thailand80
进行中（未招募）
不适用
Correction of vitamin D deficiency in critically ill patients: a randomized, doulbe-blind, placebo-controlled trialCritically ill patients with vitamin D deficiencyEUCTR2010-018798-39-ATMedizinische Universität Graz, Universitätsklinik für Innere Medizin, Abteilung für Endokrinologie480
Unknown
不适用
Vitamin D Treatment in Patients With Chronic Hepatitis CChronic Hepatitis CNCT00804752Hillel Yaffe Medical Center
进行中（未招募）
不适用
Vitamin D supplementation in chronic heart failure: a randomized, double-blind, placebo-controlled trialChronic stable heart failure (NYHA II-IV, ejection fraction = 40%)Vitamin D deficiency (defined as 25 (OH) Vitamin D = 30ng/ml)EUCTR2010-022763-35-ATMedical University of Graz
招募中
3 期
A clinical trial to study the effect of Vitamin D in patients of systemic lupus erythematosus.CTRI/2017/07/009033Bidyut Kumar Das